THE NICKLES GROUP, LLC for MERCK & CO. INC.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Issues related to drug pricing and the Medicare Part D program; monitored issues related to the Medicare outpatient payment system.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STACEY HUGHES | — |
| EMILY PORTER | — |
Health Issues HCR
Issues related to antimicrobials; issues related to the reauthorization of PAHPA; Monitored issues related to the Right to Try Act of 2018; S. 1827; Monitored issues related to Keep Kids Insurance Dependable and Secure Act of 2017; Issues related to the Animal Drug User Fee (ADUFA) and Animal Generic Drug User Fee Act (AGDUFA).
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHANIE BADGER New | — |
| STACEY HUGHES | — |
| EMILY PORTER | — |
Budget/Appropriations BUD
H.R 1892 The Bipartisan Budget Act of 2018 and issues related to Medicare drug pricing; H.R. 1625, Monitored the Consolidated Appropriations Act 2018 and issues related to Medicare drug pricing.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STACEY HUGHES | — |
| EMILY PORTER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.